Clinical trial
Segmental Substrate Isolation for the Treatment of Ventricular Tachycardia in Patients With Structural Heart Disease
NCT07814079 is registered in ClinicalTrials.gov with New York Medical College as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Segmental Substrate Isolation for the Treatment of Ventricular Tachycardia in Patients With Structural Heart Disease
- Lead sponsor
- New York Medical College
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- March 27, 2025
- Completion date
- December 9, 2028
- Enrollment
- 30 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
ischemic cardiomyopathy, nonischemic cardiomyopathy, ventricular tachycardia (vt)